Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study
W. P. Olszynski, Jonathan D. Adachi(St. Peter's Hospital), George Ioannidis(McMaster University Medical Centre), Αλεξάνδρα Παπαϊωάννου(Western University), Alan Tenenhouse(St. Vincent's Birmingham), Robert G. Josse(University of Toronto), David A. Hanley(University of Calgary), Annie Petrie(McMaster University), C. H. Goldsmith, Timothy M. Murray(Beaumont Hospital), K. Shawn Davison(University of Victoria), R. J. Sebaldt, Jacques P. Brown(Centre hospitalier de l'Université Laval)
Cited by 13
Related Papers
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
Predictive Value of BMD for Hip and Other Fractures
|Journal of Bone and Mineral Research|2005|1.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k